Genzyme Sues Seikagaku Over Synvisc-One Patent
Genzyme Corp. sued Seikagaku Corp. in Massachusetts on Thursday, claiming the Japanese pharmaceutical company's newly approved treatment for osteoarthritis knee pain infringes a patent for its knee pain relief treatment Synvisc-One....To view the full article, register now.
Already a subscriber? Click here to view full article